Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Operating activities    
Net income (loss) $ 1,133 $ 9,625
Less: gain from discontinued operations 1,871 4
Income (loss) from continuing operations (738) 9,621
Adjustments to reconcile net income (loss) to net cash used in operating activities, including effects of business acquired:    
Non-cash change in estimated fair value of contingent liabilities (513) 2,288
Accretion of deferred gain on sale leaseback   (426)
Depreciation and amortization 678 564
Non-cash lease costs   (90)
Loss (gain) on asset write-offs (10)  
Realized loss (gain) on investment (17) (23)
Stock-based compensation 709 452
Deferred income taxes (35) (14,053)
Other 85 29
Changes in operating assets and liabilities, net of acquisition:    
Accounts receivable 4,118 1,024
Inventory (44) (1,797)
Other current assets (462) 4,605
Other long term assets 175 460
Accounts payable and accrued liabilities (3,506) (970)
Other liabilities   (800)
Deferred revenue (609) 27
Net cash provided by (used in) operating activities of continuing operations (169) 911
Net cash (used in) operating activities of discontinued operations (200)  
Net cash provided by (used in) operating activities (369) 911
Investing activities    
Acquisition of CyDex, net of cash acquired   (32,024)
Payments to CVR holders (4,549)  
Purchases of property, equipment and building (19) (5)
Proceeds from sale of property, and equipment and building 13  
Purchases of short-term investments   (5,000)
Proceeds from sale of short-term investments 8,500 13,888
Other, net   (28)
Net cash provide by (used in) investing activities of continuing operations 3,945 (23,169)
Net cash provided by investing activities of discontinued operations      
Net cash provided by (used in) investing activities 3,945 (23,169)
Financing activities    
Proceeds from issuance of debt 7,500 25,000
Repayment of debt (8,500)  
Proceeds from issuance of common stock, net 160  
Share repurchases   (55)
Net cash provided by (used in) financing activities of continuing operations (840) 24,945
Net cash provided by (used in) financing activities (840) 24,945
Net increase in cash and cash equivalents 2,736 2,687
Cash and cash equivalents at beginning of period 7,041 3,346
Cash and cash equivalents at end of period 9,777 6,033
Supplemental Disclosure of cash flow information    
Interest paid 631 321
Taxes paid $ 17 $ 27